Our study demonstrates that unlike other tumors of the head and neck, there is an increase in tumor cell-specific STING expression in laryngeal cancer in the advanced stages of the disease, which could be important for the introduction of novel therapeutic options. This evidence concerns the gene STING1 and neoplasm.